Description

Book Synopsis
In this new edition of a bestseller, all the contents have been brought upto-date by addressing current standards and best practices in the assessment and prediction of ADMET properties. Although the previous chapter layout has been retained, substantial revisions have been made, with new topics such as pro-drugs, active metabolites and transporters covered in detail in a manner useful to the Drug Discovery scientist. The authors discuss the parameters and processes important for the absorption, distribution and retention of drug compounds in the body, plus the potential problems created by their transformation into toxic byproducts.

While aimed at all those dealing professionally with the development and application of pharmaceutical substances, the readily comprehensible style makes this book equally suitable for students of pharmacy and related subjects. Uniquely comprehensive, the book relates physicochemistry and chemical structure to pharmacokinetic properties and ultimately drug efficacy and safety.


Table of Contents
PHYSICOCHEMISTRY
Physicochemistry and Pharmacokinetics
Partition and Distribution Coefficients as Measures of Lipophilicity
Limitations on the Use of 1-Octanol
Further Understanding of logP
Alternative Lipophilicity Scales
Computational Systems to Determine Lipophilicity
Membrane Systems to Study Drug Behavior
Dissolution and Solubility
The BCS Classification and Central Role of Permeability

PHARMACOKINETICS
Setting the Scene
Intravenous Administration: Volume of Distribution
Intravenous Administration: Clearance
Intravenous Administration: Clearance and Half-life
Intravenous Administration: Infusion
Oral Administration
Repeated Doses
Development of the Unbound (Free) Drug Model
Unbound Drug and Drug Action
Unbound Drug Model and Barriers to Equilibrium
Pharmacodynamic Models
Slow Offset Compounds
Factors Governing Unbound Drug Concentration

ABSORPTION
The Absorption Process
Dissolution
Membrane Transfer
Barriers to Membrane Transfer
Prodrugs to Increase Oral Absorption
Active Transport
Models for Absorption Estimation
Estimation of Absorption Potential and other Computational

DISTRIBUTION
Membrane Transfer Access to the Target
Brain Penetration

CLEARANCE
The Clearance Processes
Role of Transport Proteins in Drug Clearance
Interplay Between Metabolic and Renal Clearance
Role of Lipophilicity in Drug Clearance
Active Metabolites
Balancing the Rate of Renal and Metabolic clearance and Potency

RENAL CLEARANCE
Kidney Anatomy and Function
Lipophilicity and Reabsorption by the Kidney
Effect of Charge on Renal Clearance
Plasma Protein Binding and Renal Clearance
Balancing Renal Clearance and Absorption
Renal Clearance and Drug Design

METABOLIC (HEPATIC) CLEARANCE
Symbols
Function of Metabolism (Biotransformation)
Cytochrome P450
Other Oxidative Metabolism Processes
Oxidative Metabolism and Drug Design
Nonspecific Esterases
Prodrugs to Aid Membrane Transfer
Enzymes Catalyzing Drug Conjugation
Stability to Conjugation Processes
Pharmacodynamics and Conjugation

TOXICITY
Toxicity Findings
Structure -
Toxicity Analyses
Reactive Metabolite Screening in Drug Discovery
Structural Alerts/Toxicophores in Drug Design
Dealing with Reactive Metabolite Positives in Drug Discovery: Risk Assessment Strategies -
Effect of Daily Dose
Dealing with Reactive Metabolite Positives in Drug Discovery: Risk Assessment Strategies -
Competing Detoxication Pathways
Stratification of Toxicity
Toxicity Prediction: Computational Toxicology
Toxicogenomics
Pharmacogenomics
Enzyme Induction and Drug Design
Enzyme Inhibition and Drug Design

PREDICTING HUMAN PHARMACOKINETICS
Objectives of Predicting Human Pharmacokinetics
Allometric Scaling of Preclinical In Vivo PK Parameters
Prediction of Human PK Parameters Using In Vitro Data
Elimination Half-Life
Moving Forward

ADME SCREENING
The High-Throughput Synthesis and Screening Trend
The Concept of ADME Space
Drug Metabolism and Discovery Screening Sequences
Physicochemistry
Absorption/Permeability
Metabolism, Induction, and Inhibition
Transporters
Protein Binding
Pharmacokinetics

Pharmacokinetics and Metabolism in Drug Design

    Product form

    £105.26

    Includes FREE delivery

    RRP £116.95 – you save £11.69 (9%)

    Order before 4pm today for delivery by Mon 22 Jun 2026.

    A Hardback by Dennis A. Smith, Charlotte Allerton, Amit S. Kalgutkar

    Out of stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Pharmacokinetics and Metabolism in Drug Design by Dennis A. Smith

      Publisher: Wiley-VCH Verlag GmbH
      Publication Date: 04/04/2012
      ISBN13: 9783527329540, 978-3527329540
      ISBN10:

      Description

      Book Synopsis
      In this new edition of a bestseller, all the contents have been brought upto-date by addressing current standards and best practices in the assessment and prediction of ADMET properties. Although the previous chapter layout has been retained, substantial revisions have been made, with new topics such as pro-drugs, active metabolites and transporters covered in detail in a manner useful to the Drug Discovery scientist. The authors discuss the parameters and processes important for the absorption, distribution and retention of drug compounds in the body, plus the potential problems created by their transformation into toxic byproducts.

      While aimed at all those dealing professionally with the development and application of pharmaceutical substances, the readily comprehensible style makes this book equally suitable for students of pharmacy and related subjects. Uniquely comprehensive, the book relates physicochemistry and chemical structure to pharmacokinetic properties and ultimately drug efficacy and safety.


      Table of Contents
      PHYSICOCHEMISTRY
      Physicochemistry and Pharmacokinetics
      Partition and Distribution Coefficients as Measures of Lipophilicity
      Limitations on the Use of 1-Octanol
      Further Understanding of logP
      Alternative Lipophilicity Scales
      Computational Systems to Determine Lipophilicity
      Membrane Systems to Study Drug Behavior
      Dissolution and Solubility
      The BCS Classification and Central Role of Permeability

      PHARMACOKINETICS
      Setting the Scene
      Intravenous Administration: Volume of Distribution
      Intravenous Administration: Clearance
      Intravenous Administration: Clearance and Half-life
      Intravenous Administration: Infusion
      Oral Administration
      Repeated Doses
      Development of the Unbound (Free) Drug Model
      Unbound Drug and Drug Action
      Unbound Drug Model and Barriers to Equilibrium
      Pharmacodynamic Models
      Slow Offset Compounds
      Factors Governing Unbound Drug Concentration

      ABSORPTION
      The Absorption Process
      Dissolution
      Membrane Transfer
      Barriers to Membrane Transfer
      Prodrugs to Increase Oral Absorption
      Active Transport
      Models for Absorption Estimation
      Estimation of Absorption Potential and other Computational

      DISTRIBUTION
      Membrane Transfer Access to the Target
      Brain Penetration

      CLEARANCE
      The Clearance Processes
      Role of Transport Proteins in Drug Clearance
      Interplay Between Metabolic and Renal Clearance
      Role of Lipophilicity in Drug Clearance
      Active Metabolites
      Balancing the Rate of Renal and Metabolic clearance and Potency

      RENAL CLEARANCE
      Kidney Anatomy and Function
      Lipophilicity and Reabsorption by the Kidney
      Effect of Charge on Renal Clearance
      Plasma Protein Binding and Renal Clearance
      Balancing Renal Clearance and Absorption
      Renal Clearance and Drug Design

      METABOLIC (HEPATIC) CLEARANCE
      Symbols
      Function of Metabolism (Biotransformation)
      Cytochrome P450
      Other Oxidative Metabolism Processes
      Oxidative Metabolism and Drug Design
      Nonspecific Esterases
      Prodrugs to Aid Membrane Transfer
      Enzymes Catalyzing Drug Conjugation
      Stability to Conjugation Processes
      Pharmacodynamics and Conjugation

      TOXICITY
      Toxicity Findings
      Structure -
      Toxicity Analyses
      Reactive Metabolite Screening in Drug Discovery
      Structural Alerts/Toxicophores in Drug Design
      Dealing with Reactive Metabolite Positives in Drug Discovery: Risk Assessment Strategies -
      Effect of Daily Dose
      Dealing with Reactive Metabolite Positives in Drug Discovery: Risk Assessment Strategies -
      Competing Detoxication Pathways
      Stratification of Toxicity
      Toxicity Prediction: Computational Toxicology
      Toxicogenomics
      Pharmacogenomics
      Enzyme Induction and Drug Design
      Enzyme Inhibition and Drug Design

      PREDICTING HUMAN PHARMACOKINETICS
      Objectives of Predicting Human Pharmacokinetics
      Allometric Scaling of Preclinical In Vivo PK Parameters
      Prediction of Human PK Parameters Using In Vitro Data
      Elimination Half-Life
      Moving Forward

      ADME SCREENING
      The High-Throughput Synthesis and Screening Trend
      The Concept of ADME Space
      Drug Metabolism and Discovery Screening Sequences
      Physicochemistry
      Absorption/Permeability
      Metabolism, Induction, and Inhibition
      Transporters
      Protein Binding
      Pharmacokinetics

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account